12 Results for "

CNS-active

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "CNS-active" in MCE Product Catalog:

18
18 Publications Verification
Cat. No.: HY-B0193A
CAS No.: 19237-84-4
Prazosin hydrochloride is a well-tolerated, CNS-active α1-adrenergic receptor antagonist for the research of high blood pressure and alcohol use disorders . Prazosin hydrochloride potently inhibits Norepinephrine (NE)-stimulated 45Ca efflux with an IC50 of 0.15 nM .Prazosin hydrochloride inhibits organic cation transporters OCT-1 and OCT-3 with IC50s of 1.8, and 13 μM, respectively .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-136109
CAS No.: 1310422-41-3
Purity:  99.89%
Synonyms: SEP-363856 hydrochloride; SEP-856 hydrochloride
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

SEP-363856 (SEP-856) hydrochloride, an orally active TAAR1 and 5-HT1A agonist and CNS active psychotropic agent with a unique, non-D2/5-HT2A mechanism of action, exerts its antipsychotic-like effects. SEP-363856 hydrochloride has the potential for the study of schizophrenia .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-12501A
CAS No.: 1642303-38-5
Purity:  99.19%
Research Areas:  

Neurological Disease

ITI-214 is a potent, CNS-active, orally bioavailable PDE1 inhibitor (Ki of 58 pM) with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters and ion channels. ITI-214 inhibits recombinant full-length human PDE1A, PDE1B and PDE1C with Kis of 33 pM, 380 pM and 35 pM, respectively. ITI-214 shows efficacy in various animal models of motor and cognitive functions .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-131181
CAS No.: 2393840-15-6
Purity:  99.73%
Target:  

Phospholipase

Research Areas:  

Neurological Disease

LEI-401 is a first-in-class, selective, and CNS-active NAPE-PLD (N-acylphosphatidylethanolamine phospholipase D) inhibitor, with an IC50 of 27 nM. LEI-401 modulates emotional behavior in mice .
loading...
    loading...
Cat. No.: HY-12501
CAS No.: 1160521-50-5
Purity:  ≥98.0%
Research Areas:  

Neurological Disease

ITI-214 free base is a potent, CNS-active, orally bioavailable PDE1 inhibitor (Ki of 58 pM) with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters and ion channels. ITI-214 free base inhibits recombinant full-length human PDE1A, PDE1B and PDE1C with Kis of 33 pM, 380 pM and 35 pM, respectively. ITI-214 free base shows efficacy in various animal models of motor and cognitive functions .
loading...
    loading...
Cat. No.: HY-136109A
CAS No.: 1310426-33-5
Synonyms: SEP-363856; SEP-856
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

SEP-363856 (SEP-856), an orally active TAAR1 and 5-HT1A agonist and CNS active psychotropic agent with a unique, non-D2/5-HT2A mechanism of action, exerts its antipsychotic-like effects. SEP-363856 (SEP-856) has the potential for the study of schizophrenia .
loading...
    loading...
Cat. No.: HY-12596
CAS No.: 871824-55-4
JNJ-26489112, a CNS-active agent, exhibits broad-spectrum anticonvulsant activity in rodents against audiogenic, electrically-induced, and chemically-induced seizures. JNJ-26489112 inhibits voltage-gated Na + channels and N-type Ca 2+ channels, and is effective as a K + channel opener. JNJ-26489112 has very weak inhibition of CA-II (IC50=35 μM) and CA-I (18 μM) .
loading...
    loading...
Cat. No.: HY-B0193AR
CAS No.: 19237-84-4
Prazosin (hydrochloride) (Standard) is the analytical standard of Prazosin (hydrochloride). This product is intended for research and analytical applications. Prazosin hydrochloride is a well-tolerated, CNS-active α1-adrenergic receptor antagonist for the research of high blood pressure and alcohol use disorders . Prazosin hydrochloride potently inhibits Norepinephrine (NE)-stimulated 45Ca efflux with an IC50 of 0.15 nM .Prazosin hydrochloride inhibits organic cation transporters OCT-1 and OCT-3 with IC50s of 1.8, and 13 μM, respectively .
loading...
    loading...
Cat. No.: HY-136109E
CAS No.: 2375116-27-9
Synonyms: SEP-856 mesylate
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

SEP-363856 (SEP-856) mesylate, an orally active TAAR1 and 5-HT1A agonist and CNS active psychotropic agent with a unique, non-D2/5-HT2A mechanism of action, exerts its antipsychotic-like effects. SEP-363856 mesylate has the potential for the study of schizophrenia .
loading...
    loading...
Cat. No.: HY-136109B
CAS No.: 1310426-29-9
Synonyms: (Rac)-SEP-363856; (Rac)-SEP-856
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

(Rac)-SEP-363856 is the racemate of SEP-363856. SEP-363856(SEP-856), an orally active and CNS active psychotropic agent with a unique, non-D2/5-HT2A mechanism of action, exerts its antipsychotic-like effects. SEP-363856 (SEP-856) has the potential for the treatment of schizophrenia .
loading...
    loading...
Cat. No.: HY-L0123V
30,300 compounds

The incidence and significance of central nervous system diseases are increasing at an alarming rate all over the world. Although substantial research efforts have been applied to develop new CNS-active drugs, only a few CNS disorders are addressed satisfactorily, while the remaining ones pose significant clinical challenges. Blood-brain barrier (BBB) permeability is one of the most important limiting factors in the design and development of novel CNS-targeted pharmaceuticals for the treatment of neurological disorders.

Carefully selected from the HTS Compound Collection to meet the parameters optimized for high BBB-permeability, our CNS Focused Screening Library comprising over 30,300 structurally-diverse and potentially CNS-active screening compounds. This original Screening Compound Library is aimed at supporting CNS drug design projects and HTS efforts in search for novel neurotherapeutics.

Cat. No.: HY-136109H
CAS No.: 1310422-02-6
Synonyms: (Rac)-SEP-363856 hydrochloride; (Rac)-SEP-856 hydrochloride
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

(Rac)-Ulotaront hydrochloride ((Rac)-SEP-363856 hydrochloride) is the racemate of Ulotaront hydrochloride (HY-136109). Ulotaront hydrochloride, an orally active and CNS active psychotropic agent with a unique, non-D2/5-HT2A mechanism of action, exerts its antipsychotic-like effects. Ulotaront has the potential for the treatment of schizophrenia .
loading...
    loading...
  • 1